Natural Biocon (India) Limited
Bombay Stock ExchangeTotal Valuation
Natural Biocon (India) Limited carries a market capitalization of 96.43M, placing it among publicly traded companies globally. Its enterprise value stands at 79.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 96.43M |
| Enterprise Value | 79.95M |
Share Statistics
Natural Biocon (India) Limited currently has 25.78M shares outstanding.
| Shares Outstanding | 25.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Natural Biocon (India) Limited trades at a trailing price-to-earnings ratio of 345.36. The price-to-sales ratio is 3.01, and the price-to-book ratio stands at 0.30.
| PE Ratio | 345.36 |
| PS Ratio | 3.01 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.25 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 3.14 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 370.70 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.14 |
| EV / EBITDA | 370.70 |
| EV / EBIT | 370.70 |
| EV / FCF | N/A |
Financial Position
Natural Biocon (India) Limited maintains a current ratio of 0.86, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.86 |
| Quick Ratio | 0.01 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | -8.86 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -0.16 |
| Return on Assets (ROA) | -0.11 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 26.14 |
Stock Price Statistics
Natural Biocon (India) Limited's stock has declined approximately -70.05604% over the past 52 weeks. The 50-day moving average sits at 3.64, while the 200-day moving average is 4.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -70.05604% |
| 50-Day Moving Average | 3.64 |
| 200-Day Moving Average | 4.40 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Natural Biocon (India) Limited generated 25.44M in revenue and converted that into -412,000.00 in net income, yielding earnings per share of -0.02. EBITDA reached -424,000.00, while operating income came in at -424,000.00.
| Revenue | 25.44M |
| Gross Profit | 3.69M |
| Operating Income | -424,000.00 |
| Pretax Income | -412,000.00 |
| Net Income | -412,000.00 |
| EBITDA | -424,000.00 |
| EBIT | -424,000.00 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Natural Biocon (India) Limited holds 397,000.00 in cash and equivalents against 3.76M in total debt, resulting in a net debt position of 3.36M. Total book value stands at 257.83M, with working capital of -8.72M providing operational flexibility.
| Cash & Cash Equivalents | 397,000.00 |
| Total Debt | 3.76M |
| Net Debt | 3.36M |
| Equity (Book Value) | 257.83M |
| Book Value Per Share | 10.94 |
| Working Capital | -8.72M |
Margins
Natural Biocon (India) Limited operates with a gross margin of 14.50, reflecting its pricing power and cost economics. The operating margin of -1.67 and net profit margin of -1.62 provide insight into operational efficiency.
| Gross Margin | 14.50 |
| Operating Margin | -1.67 |
| Pretax Margin | -1.62 |
| Profit Margin | -1.62 |
| EBITDA Margin | -1.67 |
Scores
Natural Biocon (India) Limited posts an Altman Z-Score of 0.79, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.79 |